Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trialJürgen Rech, Georg Schett, Koray Taşçılar et al.|The Lancet|2024Cited by 134
Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study.H. Nüßlein, Manuela Le Bars, Michael T. Nurmohamed et al.|PubMed|2016Cited by 32
Imaging rheumatoid arthritis joints with technetium-99m labelled specific anti-CD4? and non-specific monoclonal antibodiesRaimund W. Kinne, F. Wolf, W. Becker et al.|European Journal of Nuclear Medicine and Molecular Imaging|1994Cited by 24
SAT0526 ICG-Enhanced Fluorescence Optical Imaging (FOI) Detects Typical Inflammatory Changes in Subjects with Arthralgia and PsoriasisS. G. Werner, Helmut Länger, F. Spiecker et al.|Annals of the Rheumatic Diseases|2013Cited by 2
AB0754 Icg-enhanced fluorescence optical imaging detects typical inflammatory changes in asymptomatic subjects with elevated rheumatoid factor or anti-ccp antibodiesS. G. Werner, H.-E. Langer, F. Spiecker et al.|Annals of the Rheumatic Diseases|2013Cited by 0